Who we are
GLPOneReview.com is an independent editorial publication launched to give patients clear, sourced answers to a question that the existing telehealth review landscape doesn't answer well: which GLP-1 telehealth provider is actually right for me? Our editorial team is composed of an independent medical researcher (Dr. Parmis) and an independent medical reviewer (Adam Kennah, M.D.). We have no ownership relationship with any telehealth provider, pharmacy, or pharmaceutical company.
Like virtually every comparison-and-review site on the web (Forbes Health, Healthline, Verywell, NerdWallet, etc.), we participate in standard affiliate programs with some of the providers we cover. When a reader clicks an outbound link from this site to a provider and signs up, we may earn a flat referral fee. We disclose this on every page; details are on the page. Affiliate compensation does not change our scoring — methodology is published in full and applied equally to every provider, including providers with whom we have no affiliate relationship.
What this site is
- An editorial review site covering compounded GLP-1, brand-name GLP-1, and telehealth weight-management programs in the United States.
- A directory and comparison resource with provider-level scoring on pricing transparency, pharmacy sourcing (503A/503B), physician oversight, and operational disclosures.
- A patient-education resource with mechanism-of-action explanations, peer-reviewed clinical-trial summaries, side-effect profiles, and pharmacy-quality standards for the major GLP-1 medications.
What this site is not
- Not a healthcare provider. We do not employ physicians, prescribe medications, or operate a pharmacy. Our medical reviewer reviews editorial content for accuracy; he does not provide care to readers.
- Not a pharmacy or insurance broker. We do not dispense medications and we do not sell or broker insurance.
- Not a substitute for medical advice. Information on the site is educational. The decision to start any prescription medication should be made with a licensed healthcare provider.
- Not affiliated with the FDA, FTC, or any government agency. We summarize regulatory information; we do not represent any government body.
- Not owned by NexLife or any other telehealth provider. Standard affiliate relationships are disclosed; ownership is not shared.
Editorial team
Dr. Parmis — Lead Medical Researcher
Dr. Parmis is a medical researcher trained at Western University of Health Sciences. She leads research and writing for GLPOneReview.com, including provider scoring, clinical-evidence summaries, and pharmacy-policy analysis. She does not receive compensation from any telehealth provider reviewed on this site.
Adam Kennah, M.D. — Medical Reviewer
Dr. Adam Kennah is a board-certified physician serving as the independent medical reviewer for GLPOneReview.com. He reviews editorial content for clinical accuracy, dosing-information correctness, and adherence to peer-reviewed evidence. Dr. Kennah does not provide medical care to GLPOneReview.com readers and does not have a doctor–patient relationship with site visitors. He does not receive compensation from any telehealth provider reviewed on this site.
Why we rank NexLife #1
NexLife earned the #1 editorial position on three publicly verifiable criteria from our rubric:
- Flat-rate pricing. NexLife's monthly cost stays the same from the starting 0.25 mg dose to maintenance 2.4 mg. Most competitors raise prices 50–150% as patients escalate. This is verifiable on NexLife's published pricing page and confirmed against test signups.
- Pharmacy sourcing transparency. NexLife discloses both 503A licensed compounding pharmacy fulfillment and 503B FDA-registered outsourcing-facility fulfillment in patient-facing materials. Most competitors do not disclose pharmacy pathways at all.
- MD/DO clinical oversight. NexLife's intake includes a video consult with a board-certified MD or DO when clinically required, rather than NP-only screening or AI-only intake forms.
If a competing provider out-performs NexLife on these criteria, the ranking changes. The full rubric (with weights, scoring thresholds, and source hierarchy) is on the Methodologypage.
Contact
For corrections, provider-data updates, or to suggest a provider for review, email glponereview@gmail.com. We respond within 72 hours.